Skip to main content

Fluidigm to Present at Cowen and Company Annual Healthcare Conference

Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the Cowen and Company Annual Healthcare Conference on Wednesday, March 9, 2011 at the Boston Marriott Copley Place, Boston, Mass., beginning at 10:15 a.m. Eastern Time.

In this presentation, Fluidigm will discuss its 2010 financial performance and its outlook for 2011.

Audio and slides of Fluidigm’s presentation will be webcast at: http://www.wsw.com/webcast/cowen3/fldm/.

The webcast will be archived for 90 days following the live presentation.

In addition, Fluidigm will issue its press release discussing fourth quarter and fiscal 2010 operating results before the market opening on March 9, 2011. The press release will be available on the Company’s website (http://www.fluidigm.com/press-releases.html) prior to the presentation.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including chips and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems, including eight different commercial chips, to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.

For more information, please visit www.fluidigm.com.

“Fluidigm” and the Fluidigm logo are trademarks or registered trademarks of Fluidigm.

Contacts:

Fluidigm Corporation
Howard High, 650-266-6081 (office)
510-786-7378 (mobile)
howard.high@fluidigm.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.